Business Standard

SPONSORED CONTENT

What's this ?

Sponsored Content is a "Paid For" Press Release distribution arrangement. Purely a Commercial Arrangement, brands and advertisers pay to be featured and to get this content published.

The Editorial/Content team at Business Standard has not contributed to writing/editing this article.

To get your brand featured in this Section write to assist@bsmail.in

Sri Sri Tattva partners with BMCRI to study effects of Ayurveda immunomodulators on COVID-19 patients

Sri Sri Tattva partners with BMCRI to study effects of Ayurveda immunomodulators on COVID-19 patients

Topics
Sri Sri Tattva

ANI Press Release 

Tennis player James Blake
Herbal Immunomodulators

Bengaluru (Karnataka) [India], June 6 (ANI/NewsVoir): Bangalore Medical College and Research Institute will be conducting an open label, interventional and comparative study on the effect of immunity boosting herbal formulations by on 50 asymptomatic and mildly symptomatic COVID-19 confirmed patients.

The study will be aimed at early recovery in the symptoms of COVID patients by adding herbal immunoboosters which not only enhance immunity of one's body but also aid in the faster recovery of patients.

This trial is registered with CTRI as "A Clinical Study to Evaluate the Role of Herbal Immunomodulators as add on Treatment in Asymptomatic and Mildly Symptomatic COVID-19 Confirmed Cases." The trial will be conducted at Bangalore Medical College and Research Institute, Dr Jayanti, Director cum Dean, BMCRI being the Principal Investigator.

Dr. Jayanti explains

Herbal immunomodulators are substances which stimulate the components of immune system including both innate and adaptive immune responses.

Herbal Immunomodulators such as Tulasi, Garlic, Turmeric, Amla, Ashwagandha, Green Tea, Black Cumin, Ginger etc, are naturally obtained, safe and helpful in achieving optimum effectiveness of the immune system. Herbal Immunomodulators have potent anti-inflammatory, antibacterial, antiviral, stress relieving and cytoprotective properties.

The use of standardized immunomodulators of in specific doses will be helpful in achieving a higher protective antibody titers and development of more effective cell mediate immune response for protection against COVID-19.

Therapy will be monitored by reduction in pro-inflammatory markers such as IL-6, INF alfa, C-reactive protein and improvement in anti-inflammatory markers such as interferon gamma, delta and Ig G antibody titers. In addition to this, role of herbal immunomodulatory formulations of is being explored in the inhibition of viral entry in collaboration with German researchers as a part of Ayurgenomics project.

The use of these herbal immunomodulatory in synergy with existing drugs may involve the functional manipulation of multiple molecular targets leading to improved therapeutic efficacy.

"The Ayurveda herbal formulations being studied are a result of years of our R & D efforts. Over the years we have developed a range of herbal immunomodulators which have immensely benefitted people across the world. These are grouped as an Immunity Kit consisting of: 1. Amruth (Giloy) Tablets, 2. Turmeric Plus which is a combination of Turmeric and pepper, 3. Tulsi Arka, and 4. Shakti Drops which is a combination of Ashwagandha, Yastimadhu, Amruth and other herbs for a synergistic effect," said Arvind Varchaswi, Managing Director, Sri Sri Tattva, while commenting on the study.

"These are manufactured at our Ayush Premium Mark Certified unit. We are hopeful that these can relieve patients from COVID-19 and its symptoms. There is recognition now worldover that the science of Ayurveda has a significant role in helping promote better health during these times. Our trial has all the necessary permissions in place with BMCRI and we appreciate their interest in Ayurveda. We will extend all possible support and are hopeful for the successful completion of this study thereby benefiting the general populous," added Varchaswi.

This story is provided by NewsVoir. ANI will not be responsible in any way for the content of this article. (ANI/NewsVoir)

 

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Sat, June 06 2020. 23:31 IST
RECOMMENDED FOR YOU

Sri Sri Tattva partners with BMCRI to study effects of Ayurveda immunomodulators on COVID-19 patients

Sri Sri Tattva partners with BMCRI to study effects of Ayurveda immunomodulators on COVID-19 patients

Sri Sri Tattva partners with BMCRI to study effects of Ayurveda immunomodulators on COVID-19 patients

Bengaluru (Karnataka) [India], June 6 (ANI/NewsVoir): Bangalore Medical College and Research Institute will be conducting an open label, interventional and comparative study on the effect of immunity boosting herbal formulations by on 50 asymptomatic and mildly symptomatic COVID-19 confirmed patients.

The study will be aimed at early recovery in the symptoms of COVID patients by adding herbal immunoboosters which not only enhance immunity of one's body but also aid in the faster recovery of patients.

This trial is registered with CTRI as "A Clinical Study to Evaluate the Role of Herbal Immunomodulators as add on Treatment in Asymptomatic and Mildly Symptomatic COVID-19 Confirmed Cases." The trial will be conducted at Bangalore Medical College and Research Institute, Dr Jayanti, Director cum Dean, BMCRI being the Principal Investigator.

Dr. Jayanti explains

Herbal immunomodulators are substances which stimulate the components of immune system including both innate and adaptive immune responses.

Herbal Immunomodulators such as Tulasi, Garlic, Turmeric, Amla, Ashwagandha, Green Tea, Black Cumin, Ginger etc, are naturally obtained, safe and helpful in achieving optimum effectiveness of the immune system. Herbal Immunomodulators have potent anti-inflammatory, antibacterial, antiviral, stress relieving and cytoprotective properties.

The use of standardized immunomodulators of in specific doses will be helpful in achieving a higher protective antibody titers and development of more effective cell mediate immune response for protection against COVID-19.

Therapy will be monitored by reduction in pro-inflammatory markers such as IL-6, INF alfa, C-reactive protein and improvement in anti-inflammatory markers such as interferon gamma, delta and Ig G antibody titers. In addition to this, role of herbal immunomodulatory formulations of is being explored in the inhibition of viral entry in collaboration with German researchers as a part of Ayurgenomics project.

The use of these herbal immunomodulatory in synergy with existing drugs may involve the functional manipulation of multiple molecular targets leading to improved therapeutic efficacy.

"The Ayurveda herbal formulations being studied are a result of years of our R & D efforts. Over the years we have developed a range of herbal immunomodulators which have immensely benefitted people across the world. These are grouped as an Immunity Kit consisting of: 1. Amruth (Giloy) Tablets, 2. Turmeric Plus which is a combination of Turmeric and pepper, 3. Tulsi Arka, and 4. Shakti Drops which is a combination of Ashwagandha, Yastimadhu, Amruth and other herbs for a synergistic effect," said Arvind Varchaswi, Managing Director, Sri Sri Tattva, while commenting on the study.

"These are manufactured at our Ayush Premium Mark Certified unit. We are hopeful that these can relieve patients from COVID-19 and its symptoms. There is recognition now worldover that the science of Ayurveda has a significant role in helping promote better health during these times. Our trial has all the necessary permissions in place with BMCRI and we appreciate their interest in Ayurveda. We will extend all possible support and are hopeful for the successful completion of this study thereby benefiting the general populous," added Varchaswi.

This story is provided by NewsVoir. ANI will not be responsible in any way for the content of this article. (ANI/NewsVoir)

 

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

image
Business Standard
177 22

Sri Sri Tattva partners with BMCRI to study effects of Ayurveda immunomodulators on COVID-19 patients

Sri Sri Tattva partners with BMCRI to study effects of Ayurveda immunomodulators on COVID-19 patients

Bengaluru (Karnataka) [India], June 6 (ANI/NewsVoir): Bangalore Medical College and Research Institute will be conducting an open label, interventional and comparative study on the effect of immunity boosting herbal formulations by on 50 asymptomatic and mildly symptomatic COVID-19 confirmed patients.

The study will be aimed at early recovery in the symptoms of COVID patients by adding herbal immunoboosters which not only enhance immunity of one's body but also aid in the faster recovery of patients.

This trial is registered with CTRI as "A Clinical Study to Evaluate the Role of Herbal Immunomodulators as add on Treatment in Asymptomatic and Mildly Symptomatic COVID-19 Confirmed Cases." The trial will be conducted at Bangalore Medical College and Research Institute, Dr Jayanti, Director cum Dean, BMCRI being the Principal Investigator.

Dr. Jayanti explains

Herbal immunomodulators are substances which stimulate the components of immune system including both innate and adaptive immune responses.

Herbal Immunomodulators such as Tulasi, Garlic, Turmeric, Amla, Ashwagandha, Green Tea, Black Cumin, Ginger etc, are naturally obtained, safe and helpful in achieving optimum effectiveness of the immune system. Herbal Immunomodulators have potent anti-inflammatory, antibacterial, antiviral, stress relieving and cytoprotective properties.

The use of standardized immunomodulators of in specific doses will be helpful in achieving a higher protective antibody titers and development of more effective cell mediate immune response for protection against COVID-19.

Therapy will be monitored by reduction in pro-inflammatory markers such as IL-6, INF alfa, C-reactive protein and improvement in anti-inflammatory markers such as interferon gamma, delta and Ig G antibody titers. In addition to this, role of herbal immunomodulatory formulations of is being explored in the inhibition of viral entry in collaboration with German researchers as a part of Ayurgenomics project.

The use of these herbal immunomodulatory in synergy with existing drugs may involve the functional manipulation of multiple molecular targets leading to improved therapeutic efficacy.

"The Ayurveda herbal formulations being studied are a result of years of our R & D efforts. Over the years we have developed a range of herbal immunomodulators which have immensely benefitted people across the world. These are grouped as an Immunity Kit consisting of: 1. Amruth (Giloy) Tablets, 2. Turmeric Plus which is a combination of Turmeric and pepper, 3. Tulsi Arka, and 4. Shakti Drops which is a combination of Ashwagandha, Yastimadhu, Amruth and other herbs for a synergistic effect," said Arvind Varchaswi, Managing Director, Sri Sri Tattva, while commenting on the study.

"These are manufactured at our Ayush Premium Mark Certified unit. We are hopeful that these can relieve patients from COVID-19 and its symptoms. There is recognition now worldover that the science of Ayurveda has a significant role in helping promote better health during these times. Our trial has all the necessary permissions in place with BMCRI and we appreciate their interest in Ayurveda. We will extend all possible support and are hopeful for the successful completion of this study thereby benefiting the general populous," added Varchaswi.

This story is provided by NewsVoir. ANI will not be responsible in any way for the content of this article. (ANI/NewsVoir)

 

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

image
Business Standard
177 22
.